Nuveen

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,886
Total Value
326452872908
Accession Number
0000930413-25-001717
Form Type
13F-HR
Manager Name
Nuveen
Data Enrichment
97% identified
8,625 identified261 unidentified

Holdings

8,886 positions • $326.5B total value
Manager:
Search and click to pin securities to the top
Q32 Bio Inc.
Shares:55.9K
Value:$92.2K
% of Portfolio:0.0% ($92.2K/$326.5B)
Maiden Holdings, Ltd.
Shares:161.4K
Value:$92.0K
% of Portfolio:0.0% ($92.0K/$326.5B)
Kyverna Therapeutics, Inc.
Shares:47.5K
Value:$91.7K
% of Portfolio:0.0% ($91.7K/$326.5B)
VERU INC.
Shares:178.6K
Value:$87.5K
% of Portfolio:0.0% ($87.5K/$326.5B)
FRACTYL HEALTH, INC.
Shares:73.0K
Value:$86.8K
% of Portfolio:0.0% ($86.8K/$326.5B)
Acumen Pharmaceuticals, Inc.
Shares:78.4K
Value:$86.3K
% of Portfolio:0.0% ($86.3K/$326.5B)
Metagenomi, Inc.
Shares:63.2K
Value:$86.0K
% of Portfolio:0.0% ($86.0K/$326.5B)
Rekor Systems, Inc.
Shares:96.2K
Value:$85.3K
% of Portfolio:0.0% ($85.3K/$326.5B)
RENOVARO INC.
Shares:151.7K
Value:$82.4K
% of Portfolio:0.0% ($82.4K/$326.5B)
LIFETIME BRANDS, INC
Shares:16.6K
Value:$82.1K
% of Portfolio:0.0% ($82.1K/$326.5B)
Telomir Pharmaceuticals, Inc.
Shares:25.0K
Value:$80.7K
% of Portfolio:0.0% ($80.7K/$326.5B)
XBiotech Inc.
Shares:24.9K
Value:$80.6K
% of Portfolio:0.0% ($80.6K/$326.5B)
Mersana Therapeutics, Inc.
Shares:232.2K
Value:$79.9K
% of Portfolio:0.0% ($79.9K/$326.5B)
HARVARD BIOSCIENCE INC
Shares:140.0K
Value:$79.2K
% of Portfolio:0.0% ($79.2K/$326.5B)
Ramaco Resources, Inc.
Shares:11.1K
Value:$78.9K
% of Portfolio:0.0% ($78.9K/$326.5B)
Emerald Holding, Inc.
Shares:19.9K
Value:$78.2K
% of Portfolio:0.0% ($78.2K/$326.5B)
Coherus BioSciences, Inc.
Shares:95.1K
Value:$76.7K
% of Portfolio:0.0% ($76.7K/$326.5B)
Zura Bio Ltd
Shares:59.0K
Value:$76.1K
% of Portfolio:0.0% ($76.1K/$326.5B)
MAMMOTH ENERGY SERVICES, INC.
Shares:36.8K
Value:$75.2K
% of Portfolio:0.0% ($75.2K/$326.5B)
Century Therapeutics, Inc.
Shares:157.3K
Value:$74.9K
% of Portfolio:0.0% ($74.9K/$326.5B)